Ownership history in Caption Management, LLC · 11 quarters on record
This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in SUPERNUS PHARMACEUTICALS INC (SUPN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 57,700 | +29,359 | +103.6% | 0.02% | $2.9M | $49.70 |
| 2025 Q3 | ADDED | 28,341 | +8,341 | +41.7% | 0.01% | $1.4M | $47.79 |
| 2024 Q2 | UNCHANGED | 20,000 | — | 0% | 0.01% | $535K | $26.75 |
| 2024 Q1 | REDUCED | 20,000 | -30,000 | -60.0% | 0.01% | $682K | $34.11 |
| 2022 Q1 | ADDED | 50,000 | +38,000 | +316.7% | 0.02% | $1.6M | $32.32 |
| 2021 Q3 | REDUCED | 12,000 | -46,000 | -79.3% | 0.00% | $320K | $26.67 |
| 2020 Q4 | ADDED | 58,000 | +38,600 | +199.0% | 0.03% | $1.5M | $25.16 |
| 2019 Q1 | REDUCED | 19,400 | -30,600 | -61.2% | 0.04% | $681K | $35.04 |
| 2018 Q4 | ADDED | 50,000 | +35,000 | +233.3% | 0.13% | $1.7M | $33.22 |
| 2018 Q4 | REDUCED | 15,000 | -24,000 | -61.5% | 0.04% | $499K | $33.22 |
As of 2025 Q4 — sorted by position size